Accuray Inc
NASDAQ:ARAY

Watchlist Manager
Accuray Inc Logo
Accuray Inc
NASDAQ:ARAY
Watchlist
Price: 1.8 USD 2.86% Market Closed
Market Cap: 180.5m USD
Have any thoughts about
Accuray Inc?
Write Note

Intrinsic Value

The intrinsic value of one ARAY stock under the Base Case scenario is 3.98 USD. Compared to the current market price of 1.8 USD, Accuray Inc is Undervalued by 55%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ARAY Intrinsic Value
3.98 USD
Undervaluation 55%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Accuray Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ARAY cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ARAY?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Accuray Inc

Provide an overview of the primary business activities
of Accuray Inc.

What unique competitive advantages
does Accuray Inc hold over its rivals?

What risks and challenges
does Accuray Inc face in the near future?

Has there been any significant insider trading activity
in Accuray Inc recently?

Summarize the latest earnings call
of Accuray Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Accuray Inc.

Provide P/S
for Accuray Inc.

Provide P/E
for Accuray Inc.

Provide P/OCF
for Accuray Inc.

Provide P/FCFE
for Accuray Inc.

Provide P/B
for Accuray Inc.

Provide EV/S
for Accuray Inc.

Provide EV/GP
for Accuray Inc.

Provide EV/EBITDA
for Accuray Inc.

Provide EV/EBIT
for Accuray Inc.

Provide EV/OCF
for Accuray Inc.

Provide EV/FCFF
for Accuray Inc.

Provide EV/IC
for Accuray Inc.

Show me price targets
for Accuray Inc made by professional analysts.

What are the Revenue projections
for Accuray Inc?

How accurate were the past Revenue estimates
for Accuray Inc?

What are the Net Income projections
for Accuray Inc?

How accurate were the past Net Income estimates
for Accuray Inc?

What are the EPS projections
for Accuray Inc?

How accurate were the past EPS estimates
for Accuray Inc?

What are the EBIT projections
for Accuray Inc?

How accurate were the past EBIT estimates
for Accuray Inc?

Compare the revenue forecasts
for Accuray Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Accuray Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Accuray Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Accuray Inc compared to its peers.

Compare the P/E ratios
of Accuray Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Accuray Inc with its peers.

Analyze the financial leverage
of Accuray Inc compared to its main competitors.

Show all profitability ratios
for Accuray Inc.

Provide ROE
for Accuray Inc.

Provide ROA
for Accuray Inc.

Provide ROIC
for Accuray Inc.

Provide ROCE
for Accuray Inc.

Provide Gross Margin
for Accuray Inc.

Provide Operating Margin
for Accuray Inc.

Provide Net Margin
for Accuray Inc.

Provide FCF Margin
for Accuray Inc.

Show all solvency ratios
for Accuray Inc.

Provide D/E Ratio
for Accuray Inc.

Provide D/A Ratio
for Accuray Inc.

Provide Interest Coverage Ratio
for Accuray Inc.

Provide Altman Z-Score Ratio
for Accuray Inc.

Provide Quick Ratio
for Accuray Inc.

Provide Current Ratio
for Accuray Inc.

Provide Cash Ratio
for Accuray Inc.

What is the historical Revenue growth
over the last 5 years for Accuray Inc?

What is the historical Net Income growth
over the last 5 years for Accuray Inc?

What is the current Free Cash Flow
of Accuray Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Accuray Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Accuray Inc

Current Assets 323.2m
Cash & Short-Term Investments 68.6m
Receivables 92m
Other Current Assets 162.7m
Non-Current Assets 145.4m
Long-Term Investments 9.8m
PP&E 58.5m
Intangibles 57.7m
Other Non-Current Assets 19.3m
Current Liabilities 195.3m
Accounts Payable 50m
Accrued Liabilities 51.9m
Other Current Liabilities 93.4m
Non-Current Liabilities 228.3m
Long-Term Debt 164.4m
Other Non-Current Liabilities 63.9m
Efficiency

Earnings Waterfall
Accuray Inc

Revenue
446.6m USD
Cost of Revenue
-303.4m USD
Gross Profit
143.1m USD
Operating Expenses
-140m USD
Operating Income
3.1m USD
Other Expenses
-18.6m USD
Net Income
-15.5m USD

Free Cash Flow Analysis
Accuray Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In its strongest revenue quarter ever, Accuray reported $134 million in Q4 2024, a 14% year-over-year increase driven by a record number of system shipments and robust international demand. Total annual revenue was $447 million, flat from the previous year, but notable gains were seen internationally, particularly with 80% of revenue coming from markets outside the U.S. The company anticipates growth in these regions to continue, while a cautious recovery in the U.S. is expected in the latter half of FY 2025. For FY 2025, Accuray guides a revenue range of $460-$470 million and adjusted EBITDA of $27.5-$29.5 million.

What is Earnings Call?
Fundamental Scores

ARAY Profitability Score
Profitability Due Diligence

Accuray Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Positive 3-Years Revenue Growth
Negative Free Cash Flow
35/100
Profitability
Score

Accuray Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

ARAY Solvency Score
Solvency Due Diligence

Accuray Inc's solvency score is 23/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Positive Net Debt
High D/E
23/100
Solvency
Score

Accuray Inc's solvency score is 23/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ARAY Price Targets Summary
Accuray Inc

Wall Street analysts forecast ARAY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ARAY is 6.25 USD with a low forecast of 5.56 USD and a high forecast of 7.35 USD.

Lowest
Price Target
5.56 USD
209% Upside
Average
Price Target
6.25 USD
247% Upside
Highest
Price Target
7.35 USD
308% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ARAY?

Click here to dive deeper.

Dividends

Accuray Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ARAY is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ARAY Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Accuray Inc Logo
Accuray Inc

Country

United States of America

Industry

Health Care

Market Cap

180.4m USD

Dividend Yield

0%

Description

Accuray, Inc. is a radiation oncology company. The company is headquartered in Sunnyvale, California and currently employs 995 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports market-changing solutions that are designed to deliver radiation treatments. The firm's technologies include the CyberKnife and TomoTherapy platforms, including the Radixact System. The CyberKnife and TomoTherapy platform, which are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT) and adaptive radiation therapy (ART). The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.

Contact

CALIFORNIA
Sunnyvale
1310 Chesapeake Ter
+14087164600.0
www.accuray.com

IPO

2007-02-08

Employees

995

Officers

President, CEO & Director
Ms. Suzanne Winter M.B.A.
Senior VP & CFO, Interim Principal Accounting officer
Mr. Ali Pervaiz
Senior Vice President of Global Operations
Mr. Michael Hoge
Senior VP, Chief Legal Officer & Company Secretary
Mr. Jesse Chew
Senior VP & Chief Commercial Officer
Mr. Sandeep Chalke
Senior VP, Chief Information & Security Officer
Mr. John M. Dunn
Show More
Public Relations Director
Beth Kaplan
Senior VP, Chief Human Resources Officer
Ms. Melanie Rivers
Senior VP, Chief Quality & Development Officer
Mr. Jim Dennison
Senior VP & Chief Medical Officer
Dr. Seth Blacksburg M.B.A., M.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one ARAY stock?

The intrinsic value of one ARAY stock under the Base Case scenario is 3.98 USD.

Is ARAY stock undervalued or overvalued?

Compared to the current market price of 1.8 USD, Accuray Inc is Undervalued by 55%.

Back to Top